Home » Topics » Regulatory

Regulatory
RSS

Cardizem Monovial approved for U.S. marketing

Sep. 23, 1997

Clinical trials begin with topical impotence treatment

Sep. 23, 1997

Octreotide acetate clinical study commences for new indication

Sep. 23, 1997

Celgene's thalidomide approvable for ENL

Sep. 23, 1997

FDA panel recommends approval of Paxene

Sep. 22, 1997

First approvals for Lovenox/Clexane in unstable angina/MI

Sep. 22, 1997

Famvir approved by FDA for new indication

Sep. 22, 1997

Phase I results reported for MiKasome

Sep. 22, 1997

Andrx's extended-release diltiazem receives tentative approval

Sep. 22, 1997

Tacrolimus ointment effective in animal model of contact dermatitis

Sep. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...